We invite all current and prospective shareholders, partners, and other interested parties to browse our web site to learn more about Cotinga.

Investor inquiries can be directed to

Cotinga Pharmaceuticals Investor Relations
1-800-798-8680
Email: ir@cotingapharma.com

Mailing address:

United States
127 Main Street
Boston, MA
02129
Canada
100 Collip Circle, Suite 230B
London, ON
N6G 4X8